-
Self-Adjusting Lenses Designed for Eyeglasses
An engineering lab at University of Utah developed a system with eyeglass lenses that automatically adjust to the focus of the wearer, to replace bifocals and reading glasses.
-
Trial Planned to Evaluate CTE Blood Test
A clinical trial is planned of a blood test to detect an indicator of chronic traumatic encephalopathy. or CTE. a neurodegenerative disease associated with collision sports.
-
Allergy Immunotherapy Firm Raises $2M in Early Funds
A biotechnology company in Finland developing an allergy vaccine that harnesses the immune system is raising €1.85 million ($US 2 million) in its first venture funding round.
-
News Blackout Imposed on U.S. Science Agencies [Updated]
Multiple news services today are reporting that the Trump administration is ordering several U.S. government agencies conducting or funding scientific research to cease discussing its activities with the media or public officials.
-
Neuro Device Company to Begin Clinical Trials in Europe
Clinical trials in Europe are set to begin to test a non-invasive device that stimulates nerves and the spinal cord to treat neuromotor disorders.
-
Biopharm, Hospital to Partner on Cell Energy Diseases
A biopharmaceutical company in Sweden and children’s hospital in the U.S. are collaborating on research into deficiencies in cells’ energy components responsible for a number of genetic disorders.
-
Safer Engineered-Cell Cancer Immunotherapy Designed
A biotechnology company designed a new type of engineered T-cell from the immune system that more precisely targets tumors and stays away from healthy cells.
-
FDA Begins Cancer Product Review Center
The U.S. Food and Drug Administration is reorganizing its review of treatments for cancer into a structure that cuts across its traditional bureaucratic lines.
-
Lilly Acquires Migraine Therapy Company in $960M Deal
Drug maker Eli Lilly and Company is acquiring CoLucid Pharmaceuticals, a developer of treatments for migraine pain and associated symptoms.
-
UC San Francisco, Intel Partner on Health Analytics
Intel Corporation and University of California in San Francisco are developing a data analytics platform that harnesses artificial intelligence to help front-line clinicians make better decisions for their patients.